MRK | Fox Lake Towing and Recovery

Tag: MRK

The 10 Biggest-Selling Drugs That Are About to Lose Their Patent

by Melly Alazraki on Feb.27, 2011, under Towing

The pharmaceutical industry is ready to fall off a cliff — a “patent cliff.” Over the next few years, some of the world’s most popular and lucrative medicines will go off patent, and generic competition will siphon an estimated quarter of a trillion dollars from drugmakers’ bottom lines.

Continue reading The 10 Biggest-Selling Drugs That Are About to Lose Their Patent

The 10 Biggest-Selling Drugs That Are About to Lose Their Patent originally appeared on DailyFinance on Sun, 27 Feb 2011 08:00:00.

Filed Under: Company News, Investing, Health Care, Johnson & Johnson, Pfizer, Bristol-Myers Squibb, Merck, Eli Lilly, Astrazeneca

Leave a Comment :@aoloriginal, actos, AMGN, AstraZeneca, AZN, biologic, biosimilar, biotech, BMY, Bristol-Myers Squibb, Company News, concerta, drug pipeline, drugs, earnings, Eli Lilly, enbrel, generic drugs, GENZ, Health Care, Investing, JNJ, Johnson & Johnson, johnson and johnson, Levaquin, Lipitor, LLY, Merck, MRK, MRK, PFE, LLY, JNJ, SNY, BMY, NVS, AZN,TEVA, AMGN, GENZ, NVS, outlook, patent, patent cliff, pfe, Pfizer, pharmaceutical industry, pharmaceutical stocks, pharmaceuticals, plavix, protonix, research and development, sales, sanofi-aventis, Seroquel, Singulair, SNY, Takeda, TEVA, zyprexa more...

Pharmaceuticals Look Beyond Medications to Smartphone Apps

by Melly Alazraki on Feb.16, 2011, under Towing

Pharmaceutical companies looking for fresh sources of profit are increasingly investing in a range of health care innovations that aren’t drugs at all, from smartphone apps and educational websites to social media platforms and wireless devices, reports Ernst & Young.

Continue reading Pharmaceuticals Look Beyond Medications to Smartphone Apps

Pharmaceuticals Look Beyond Medications to Smartphone Apps originally appeared on DailyFinance on Wed, 16 Feb 2011 11:10:00.

Filed Under: Health Care, Pfizer, Qualcomm, Apple, Sanofi Aventis, Merck, GlaxoSmithKline, Novartis, Cisco Systems

Leave a Comment :@aoloriginal, AAPL, AAPL, PFE, MRK, SNY, NVS, GSK, QCOM, CSCO, MDT, Apple, cancer, Cisco Systems, CSCO, diabetes, drugs, Ernst Young, glaxosmithkline, GSK, Health Care, initiative, innovation, iphone, iphone app, MDT, medication, Merck, mobile health technology, MRK, Novartis, NVS, oncology, pfe, Pfizer, Pharma 3.0, pharmaceutical industry, pharmaceutical stocks, pharmaceuticals, QCOM, Qualcomm, sanofi-aventis, smart pill, smartphone, smartphone apps, SNY, treatment, weight loss, wireless devices more...

Inside Wall Street: Two Good Reasons for Clinical Data Shares to Soar Again

by Gene Marcial on Feb.14, 2011, under Towing

From October 2010 to February 2011, biotech Clinical Data’s stock doubled, mostly thanks to FDA approval of its novel antidepressant. But also pushing the stock up — and making it likely to perhaps double again — is speculation that a Big Pharma will buy Clinical Data.

Continue reading Inside Wall Street: Two Good Reasons for Clinical Data Shares to Soar Again

Inside Wall Street: Two Good Reasons for Clinical Data Shares to Soar Again originally appeared on DailyFinance on Mon, 14 Feb 2011 08:00:00.

Filed Under: Company News, Columns, Investing, Health Care, Pfizer, Stock Picks, Merck, GlaxoSmithKline, Eli Lilly

Leave a Comment :@aoloriginal, anticancer drug, antidepressants, big pharma, biotech, biotech stocks, CLDA, CLDA, PFE, LLY, GSK, MRK, FRX, ZIOP, Clinical Data, Columns, Company News, drugmakers, Eli Lilly, FDA approval, FRX, glaxosmithkline, GSK, Health Care, Intrexon, Investing, LLY, Merck, MRK, pfe, Pfizer, Randal J. Kirk, Stock Picks, Viibryd, Vilazodone, ZIOP, ziopharm more...

Week in Preview: January Employment Data, UPS Earnings and More

by Trey Thoelcke on Jan.30, 2011, under Towing

The all-important January employment reports come out this week. Also worth watching for are a host of earnings releases, led by economic bellwhether UPS. The package deliverer is expected to post strong results.

Continue reading Week in Preview: January Employment Data, UPS Earnings and More

Week in Preview: January Employment Data, UPS Earnings and More originally appeared on DailyFinance on Sun, 30 Jan 2011 10:30:00.

Filed Under: Company News, Economy, Investing, Earnings, UPS, Stocks in the News

Leave a Comment :@aoloriginal, ADM, ADP, ADP National Employment Report, AET, AFL, AMP, analyst forecasts, AVY, Ben Bernanke, bp, BRCM, CEG, Challenger Gray Christmas, CI, CLX, CMI, coinstar, Coinstar earnings, Company News, CSTR, CVS, DO, Dow, earnings, earnings previews, Earnings reports, economic data, economy, economy recovery, EL, employment, ERTS, GCI, GDP, GR, hiring, hiring outlook, HOT, HSP, HSY, IHG, Investing, ISM, jobs report, K, Las Vegas Sands, Las Vegas Sands earnings, LVS, MA, MAT, mgm, MRK, MRO, NDAQ, NVLS, nyt, pfe, RAI, sne, Stocks in the News, TM, TMO, TSN, TWX, unemployment, unemployment rate, United Parcel Service, ups, ups earnings, UPS, CSTR, LVS, AET, AFL, AMP, AVY, BP, BRCM, CEG, CMI, DOW, ERTS, EL, GR, MRO, MA, NVLS, SNE, TWX, TSN, V, WHR, YUM, IHG, MGM, GCI, HSP, K, MAT, MRK, NDAQ, RAI, TMO, ADM, CI, CLX, CVS, DO, HSY, NYT, , V, WHR, YUM more...

As Diabetes Explodes, Big Pharma Is Gearing Up

by Melly Alazraki on Jan.27, 2011, under Towing

Diabetes is a growing global scourge, but for Big Pharma it’s more of a lifesaver — and many drugmakers are cranking up their research efforts. After all, many existing drugs will soon be losing their patents, and diabetes could be a $55 billion market by 2019.

Continue reading As Diabetes Explodes, Big Pharma Is Gearing Up

As Diabetes Explodes, Big Pharma Is Gearing Up originally appeared on DailyFinance on Thu, 27 Jan 2011 18:00:00.

Filed Under: Investing, Health Care, Bristol-Myers Squibb, Sanofi Aventis, Merck, GlaxoSmithKline, Eli Lilly, Astrazeneca